MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$592.02
−0.23%Forward multiples
Based on analyst estimates
- P/E forward
- 32.22x
- P/E 2026E
- 33.38x
- P/E 2027E
- 30.37x
- P/E 2028E
- 27.33x
- P/S forward
- 5.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- 34.04x
- PEG TTM
- 5.96x
- Price / book
- 38.09x
- Price / sales
- 5.94x
- Price / cash flow
- 21.95x
Enterprise value
- Enterprise value
- $16.1B
- EV / sales
- 5.80x
- EV / EBITDA
- 26.81x
- EV / EBIT
- 27.67x
- Market cap
- $16.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026